| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia.
|
Gastroenterology
|
1994
|
3.15
|
|
2
|
Gastroenterological oncology: a top priority.
|
Dig Liver Dis
|
2000
|
1.70
|
|
3
|
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.
|
Ital J Gastroenterol Hepatol
|
1997
|
1.63
|
|
4
|
Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE).
|
Dig Liver Dis
|
2001
|
1.50
|
|
5
|
Autoimmune gastritis: histology phenotype and OLGA staging.
|
Aliment Pharmacol Ther
|
2012
|
1.48
|
|
6
|
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
|
Cancer
|
1999
|
1.43
|
|
7
|
Upper gastrointestinal injury caused by diquat.
|
Gastrointest Endosc
|
1992
|
1.41
|
|
8
|
Hormonal treatment of hepatocellular carcinoma.
|
J Hepatol
|
1991
|
1.38
|
|
9
|
The long term outcome of gastric non-invasive neoplasia.
|
Gut
|
2003
|
1.37
|
|
10
|
Association between reactive oxygen species and disease activity in chronic hepatitis C.
|
Free Radic Biol Med
|
1996
|
1.24
|
|
11
|
Gastric epithelial dysplasia. How clinicopathologic background relates to management.
|
Cancer
|
1995
|
1.13
|
|
12
|
Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
|
J Viral Hepat
|
2008
|
1.11
|
|
13
|
Squamous cell carcinoma antigen in human liver carcinogenesis.
|
J Clin Pathol
|
2007
|
1.10
|
|
14
|
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia.
|
Hum Pathol
|
1991
|
1.10
|
|
15
|
Fine-needle biopsy in focal liver lesions: the usefulness of a screening programme and the role of cytology and microhistology.
|
Ital J Gastroenterol
|
1995
|
1.04
|
|
16
|
Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia?
|
Histopathology
|
1993
|
1.03
|
|
17
|
Follow-up in gastric dysplasia patients.
|
Am J Surg Pathol
|
1989
|
1.03
|
|
18
|
The role of cysteine and serine proteases in colorectal carcinoma.
|
Cancer
|
1999
|
1.03
|
|
19
|
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria.
|
Am J Transplant
|
2007
|
1.03
|
|
20
|
Atrophic gastritis: pathology and endoscopy in the reversibility assessment.
|
Gut
|
2003
|
0.98
|
|
21
|
Extended lymphadenectomy (D2) in patients with early gastric cancer.
|
Eur J Surg Oncol
|
2005
|
0.97
|
|
22
|
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer.
|
Dig Liver Dis
|
2002
|
0.95
|
|
23
|
DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study.
|
J Hepatol
|
2001
|
0.95
|
|
24
|
Proteases in gastrointestinal neoplastic diseases.
|
Clin Chim Acta
|
2000
|
0.93
|
|
25
|
Cholestatic jaundice as the presenting symptom of small cell lung cancer.
|
Ital J Gastroenterol
|
1990
|
0.90
|
|
26
|
Is mild gastric epithelial dysplasia an indication for follow-up?
|
J Clin Gastroenterol
|
1983
|
0.89
|
|
27
|
H. pylori eradication and gastric precancerous lesions.
|
Gastroenterology
|
1998
|
0.89
|
|
28
|
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1.
|
J Clin Endocrinol Metab
|
2013
|
0.87
|
|
29
|
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.
|
Curr Pharm Des
|
2002
|
0.87
|
|
30
|
The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results.
|
Dig Liver Dis
|
2006
|
0.87
|
|
31
|
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
|
Aliment Pharmacol Ther
|
2009
|
0.87
|
|
32
|
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients.
|
Transplant Proc
|
2009
|
0.86
|
|
33
|
Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis.
|
Cancer
|
1994
|
0.86
|
|
34
|
HBV and HCV infections in heart transplant recipients.
|
J Heart Lung Transplant
|
2001
|
0.86
|
|
35
|
Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.
|
Clin Exp Metastasis
|
1997
|
0.85
|
|
36
|
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study.
|
Ital J Gastroenterol
|
1991
|
0.85
|
|
37
|
Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature.
|
Ann Oncol
|
2006
|
0.82
|
|
38
|
Gastric epithelial dysplasia in relapsing and nonrelapsing gastric ulcer.
|
Am J Gastroenterol
|
1982
|
0.82
|
|
39
|
Diagnosis of gastric carcinoma in Japan and western countries.
|
Lancet
|
1997
|
0.81
|
|
40
|
Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma.
|
J Intern Med
|
2005
|
0.81
|
|
41
|
Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma.
|
Aliment Pharmacol Ther
|
2006
|
0.81
|
|
42
|
Helicobacter pylori and gastric cancer: both primary and secondary preventive measures are required.
|
Arch Intern Med
|
1999
|
0.80
|
|
43
|
Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy.
|
J Clin Pathol
|
2005
|
0.79
|
|
44
|
TAG-72 serum determination in early and advanced gastric cancer.
|
Int J Cancer
|
1989
|
0.79
|
|
45
|
Effect of age on gastric acid, pepsin, pepsinogen group A and gastrin secretion in peptic ulcer patients.
|
Gerontology
|
1994
|
0.79
|
|
46
|
Re: Helicobacter pylori and atrophic gastritis: importance of the cagA status.
|
J Natl Cancer Inst
|
1996
|
0.79
|
|
47
|
The phenotype of gastric mucosa coexisting with Barrett's oesophagus.
|
J Clin Pathol
|
2001
|
0.78
|
|
48
|
Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
|
Hepatology
|
1999
|
0.78
|
|
49
|
Experimental hepatology applied to stem cells.
|
Dig Liver Dis
|
2007
|
0.78
|
|
50
|
Complications of radiofrequency thermal ablation in hepatocellular carcinoma: what about "explosive" spread?
|
Gut
|
2006
|
0.78
|
|
51
|
Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions.
|
Gut
|
2003
|
0.78
|
|
52
|
[Prognostic role of cisteine and serin proteases in gastriC cancer].
|
Orv Hetil
|
1996
|
0.78
|
|
53
|
Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer.
|
Am J Gastroenterol
|
1997
|
0.78
|
|
54
|
Carcinoembryonic antigen in gastric juice collected during endoscopy. Value in detecting high-risk patients and gastric cancer.
|
Cancer
|
1983
|
0.77
|
|
55
|
Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses.
|
Dig Dis Sci
|
1991
|
0.77
|
|
56
|
Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
|
Anticancer Res
|
1996
|
0.77
|
|
57
|
Occult hepatitis B virus infection.
|
Dig Liver Dis
|
2000
|
0.77
|
|
58
|
An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells.
|
J Mol Med (Berl)
|
2005
|
0.77
|
|
59
|
Clinical markers of slow healing and relapsing gastric ulcer.
|
Gut
|
1987
|
0.77
|
|
60
|
Transcatheter arterial chemoembolization in hepatocellular carcinoma.
|
Hepatology
|
1998
|
0.76
|
|
61
|
CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels.
|
Hepatogastroenterology
|
1994
|
0.76
|
|
62
|
The effects of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA.
|
Alcohol Clin Exp Res
|
1986
|
0.76
|
|
63
|
Megestrol treatment in patients with hepatocellular carcinoma.
|
Br J Cancer
|
2001
|
0.76
|
|
64
|
HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
|
Transplant Proc
|
2008
|
0.76
|
|
65
|
[The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer].
|
Orv Hetil
|
1999
|
0.76
|
|
66
|
Sex hormones and trace elements in rat CCL4-induced cirrhosis and hepatocellular carcinoma.
|
Eur J Cancer Prev
|
1993
|
0.75
|
|
67
|
Octreotide and hepatocellular carcinoma.
|
Br J Cancer
|
2007
|
0.75
|
|
68
|
Chemotherapy v symptomatic treatment for hepatoma.
|
Gut
|
1994
|
0.75
|
|
69
|
Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
|
Am J Gastroenterol
|
1995
|
0.75
|
|
70
|
Gastric precancerous lesion follow up based on pathological evidence.
|
J Clin Pathol
|
2004
|
0.75
|
|
71
|
A reappraisal of the Barcelona Clinic Liver Cancer model: natural history of untreated 'intermediate stage' hepatocellular carcinoma.
|
J Intern Med
|
2004
|
0.75
|
|
72
|
Gastric epithelial dysplasia.
|
Gut
|
1991
|
0.75
|
|
73
|
Monitoring liver regeneration after right hepatectomy.
|
Ital J Surg Sci
|
1985
|
0.75
|
|
74
|
Letter: coffee and chronic liver damage.
|
Aliment Pharmacol Ther
|
2014
|
0.75
|
|
75
|
Cysteine and glutathione in the liver of patients with primary biliary cirrhosis.
|
J Hepatol
|
1996
|
0.75
|
|
76
|
Risk of hepatocellular carcinoma in alcoholic cirrhosis.
|
Liver
|
1991
|
0.75
|
|
77
|
Tamoxifen treatment in hepatocellular carcinoma.
|
Gastroenterology
|
1996
|
0.75
|
|
78
|
Coffee, chronic diseases and cancer.
|
Eur J Clin Nutr
|
2013
|
0.75
|
|
79
|
[Role and behavior of cathepsin B and cathepsin L in gastric cancer].
|
Orv Hetil
|
1995
|
0.75
|
|
80
|
Serum and salivary caffeine clearance in cirrhosis. Any role in selection for surgery and timing for transplantation?
|
J Hepatol
|
1993
|
0.75
|
|
81
|
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
|
J Med
|
1984
|
0.75
|
|
82
|
[Basal and postprandial blood gastrin in peptic ulcer. The physiopathological considerations in relation to different locations of the lesion].
|
Minerva Med
|
1989
|
0.75
|
|
83
|
Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis.
|
Ital J Gastroenterol
|
1996
|
0.75
|
|
84
|
Consensus statement on diet and gastric cancer. Gastric Cancer Panel.
|
Eur J Cancer Prev
|
1997
|
0.75
|
|
85
|
[Development of gastric carcinoma at the site of a preceding peptic ulcer after 10 years].
|
Minerva Dietol Gastroenterol
|
1990
|
0.75
|
|
86
|
[Intragastric pH determination as a screening test in the diagnosis of chronic atrophic gastritis].
|
Minerva Med
|
1989
|
0.75
|
|
87
|
Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue.
|
Drug Metab Dispos
|
1985
|
0.75
|
|
88
|
Epithelial dysplasia in endoscopic gastric mucosal biopsies.
|
Tumori
|
1981
|
0.75
|
|
89
|
[Changes in the gastric mucosa in the treatment of ulcerative disease].
|
Minerva Dietol Gastroenterol
|
1987
|
0.75
|
|
90
|
[The use of intra-arterial lipiodol in assessing hepatocarcinomas treated by percutaneous alcoholization. The initial experience].
|
Radiol Med
|
1992
|
0.75
|
|
91
|
Granular cell myoblastoma of the esophagus: endoscopic diagnosis and therapy.
|
Gastrointest Endosc
|
1985
|
0.75
|
|
92
|
[Methodological aspects of gastric acid examination].
|
Minerva Med
|
1986
|
0.75
|
|
93
|
The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer.
|
Acta Physiol Hung
|
1995
|
0.75
|
|
94
|
Predictors of duodenal ulcer relapse: a 12-month study in untreated patients.
|
Gastroenterol Clin Biol
|
1985
|
0.75
|
|
95
|
Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
|
J Med
|
1986
|
0.75
|
|
96
|
Role of serum fasting gastrin in screening for hypergastrinemic syndromes in duodenal ulcer disease.
|
Clin Biochem
|
1992
|
0.75
|
|
97
|
The risk of gastric dysplasia in medical long-term treatment of peptic ulcer disease.
|
Scand J Gastroenterol Suppl
|
1985
|
0.75
|
|
98
|
[Ultrasound guided fine-needle aspiration biopsy in the diagnosis of hepatocellular carcinoma].
|
Orv Hetil
|
1995
|
0.75
|
|
99
|
Gastric juice CEA levels: importance of age and gastric mucosal damage.
|
Eur J Cancer Clin Oncol
|
1986
|
0.75
|
|
100
|
Tumour markers in gastrointestinal malignancies: an update.
|
Eur J Cancer Prev
|
1992
|
0.75
|
|
101
|
[Bleeding of gastric ulcers. Epidemiologic, clinical and functional characteristics].
|
Minerva Med
|
1990
|
0.75
|
|
102
|
Occurrence of an atypical alkaline phosphatase fraction ("biliary") in primary liver cancer.
|
Clin Biochem
|
1983
|
0.75
|
|
103
|
[N-acetylneuraminic acid after pentagastrin and secretin in subjects with duodenal ulcer and non-ulcerative dyspepsia].
|
Minerva Dietol Gastroenterol
|
1987
|
0.75
|
|
104
|
[Local transcatheter arterial chemoembolization in the palliative treatment of inoperable hepatocellular carcinoma].
|
Orv Hetil
|
1995
|
0.75
|
|
105
|
[Benign and malignant gastric ulcers: is their localization relevant in their differential diagnosis?].
|
Minerva Med
|
1983
|
0.75
|
|
106
|
[Peptic ulcer and liver cirrhosis. Clinico-epidemiologic considerations].
|
Minerva Med
|
1990
|
0.75
|
|
107
|
A new method for detecting anti Helicobacter pylori antibodies: an analytical and clinical evaluation.
|
J Clin Lab Anal
|
1994
|
0.75
|